Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S3 from Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial
  1. Home
  2. Publications
  3. Supplementary Figure S3 from Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial

Supplementary Figure S3 from Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial

Authors:
  • ABAdithya Balasubramanian
    Adithya Balasubramanian
  • CMClaire Marceaux
    Claire Marceaux
  • SKSehrish Kanwal
    Sehrish Kanwal
  • ITIlariya Tarasova
    Ilariya Tarasova
  • DBDaniel Batey
    Daniel Batey
  • CSClare Senko
    Clare Senko
  • KAKhashayer Asadi
    Khashayer Asadi
  • KYKenta Yokote
    Kenta Yokote
  • JPJodie Palmer
    Jodie Palmer
  • MCMichael Christie
    Michael Christie
  • AGAshray Gunjur
    Ashray Gunjur
  • SASurein Arulananda
    Surein Arulananda

Open Access
Publisher website
Google Scholar
  • 14 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30618210
Abstract
Supplementary Figure 3. Analysis of immune cell populations in all samples
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • LUNG CANCER
  • TUMOR MICROENVIRONMENT
  • IMMUNE CELLS AND THE MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.